Introduction: The high incidence of breast cancer combined with the growing number of innovative and complex treatment options, such as oral tumor therapies, is increasingly shifting oncological care
Background In Vietnam, trastuzumab is included in social health insurance’s benefits package with a reimbursement rate of 60%, but policymakers have been concerned about its cost-effectiveness. The re